Diagnosed with schizophrenia or schizoaffective disorder according to DSM-5
Has a score ≥ 7 on Calgary depression scale for schizophrenia
The principal psychotropic agents are not changed within one month of the first session of rTMS
You may not be if
DSM-5 defined substance use disorder (excluding tobacco) in the past 3 months
Have clinically relevant cognitive impairment (e.g., delirium, intellectual disability or MMSE \< 15)
With electronic and/or magnetic implants (e.g. pacemaker, implantable cardioverter defibrillator \[ICD\], cerebral shunts, cochlear implant, etc.)
With metallic or mechanic fragments (e.g., screws, plates, stents, clips, etc.)
Pregnant, or has a pregnancy plan within 3 months
With any known or history of neurological conditions including cerebral vascular accidents, epilepsy (or epileptiform waves detected by EEG prior to the first session of rTMS), brain tumor or space occupying lesion
Received rTMS or iTBS treatment within 3 months
Has a clinically significant abnormality on the screening examination that might affect safety, study participation, or confound interpretation of study results
Clareo Health | rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients
